3 Blockbuster Drug Launches to Watch This Year

3 Blockbuster Drug Launches to Watch This Year
Cory Renauer, The Motley Fool
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

The coronavirus pandemic has impacted lots of industries but it didn't slow down the pace of new drug approvals. The FDA greenlighted 59 new drugs last year, and 2021 is shaping up to be a big year too. Read on to see why new drugs from GlaxoSmithKline (NYSE: GSK), Gilead Sciences (NASDAQ: GILD), and Eli Lilly (NYSE: LLY) made the list.